Skip to content
2000
  • E-ISSN:

Abstract

Objective:

This study sought to analyze the 18F-FDG PET/CT and contrast-enhanced computed tomography (CT) images of synchronous colorectal cancer (CRC) and renal clear cell carcinoma (ccRCC) and identify the shared genes between these two types of cancer through bioinformatic analysis.

Methods:

A retrospective analysis was conducted on a patient with synchronous CRC and ccRCC who underwent 18F-FDG PET/CT and contrast-enhanced CT before treatment. Databases were analyzed to identify differentially expressed genes between CRC and ccRCC, and co-expression genes were extracted for RCC and CRC.

Results:

18F-FDG PET/CT revealed intense metabolic activity in the primary colorectal lesion (SUVmax 13.2), while a left renal mass (diameter = 35 mm) was observed with no significant uptake. Contrast-enhanced CT during the arterial phase showed heterogeneous intense enhancement of the renal lesion, and the lesion washed out earlier than in the renal cortex in the nephrographic and excretory phases, indicating ccRCC. The histopathological results confirmed synchronous double primary malignant tumors. Our bioinformatic analysis results showed that synchronous occurrence of CRC and ccRCC may correlate with simultaneous expression of Carbonic Anhydrase 9 (CA9), integrin-binding sialoprotein (IBSP), and Fibrinogen γ chain (FGG).

Conclusion:

18F-FDG PET/CT combined with contrast-enhanced CT is an effective diagnostic tool in evaluating synchronous CRC and RCC. By analyzing this clinical case and conducting bioinformatic analysis, we improved our current understanding of the mechanisms underlying synchronous tumors.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cmim/10.2174/0115734056258908230920063040
2023-10-14
2025-01-10
Loading full text...

Full text loading...

/deliver/fulltext/cmim/20/1/e15734056258908.html?itemId=/content/journals/cmim/10.2174/0115734056258908230920063040&mimeType=html&fmt=ahah

References

  1. GraceS. MuzaffarR. VeerapongJ. AlkaadeS. PoddarN. PhillipsN. GuzmanM. BatanianJ. VoglerC. LaiJ.P. Synchronous quadruple primary neoplasms: Glioblastoma, neuroendocrine tumor, schwannoma and sessile serrated adenoma in a patient with history of prostate cancer.Anticancer Res.20153542121212725862868
    [Google Scholar]
  2. MeeksM.W. GraceS. ChenY. PetterchakJ. BolestaE. ZhouY. LaiJ.P. Synchronous quadruple primary neoplasms: Colon adenocarcinoma, collision tumor of neuroendocrine tumor and schwann cell hamartoma and sessile serrated adenoma of the appendix.Anticancer Res.20163684307431127466549
    [Google Scholar]
  3. CapraF. ScintuF. ZorcoloL. MarongiuL. CasulaG. Synchronous colorectal and renal carcinomas. Is it a definite clinical entity?Chir. Ital.200355690390614725233
    [Google Scholar]
  4. HalakM. HazzanD. KovacsZ. ShiloniE. Synchronous colorectal and renal carcinomas: A noteworthy clinical entity.Dis. Colon Rectum20004391314131510.1007/BF0223744411005504
    [Google Scholar]
  5. YamamotoS. YoshimuraK. RiS. FujitaS. AkasuT. MoriyaY. The risk of multiple primary malignancies with colorectal carcinoma.Dis. Colon Rectum2006491S30S3610.1007/s10350‑006‑0600‑817106813
    [Google Scholar]
  6. RabbaniF. ReuterV.E. KatzJ. RussoP. Second primary malignancies associated with renal cell carcinoma: Influence of histologic type.Urology200056339940310.1016/S0090‑4295(00)00682‑810962302
    [Google Scholar]
  7. CastaldiP. LeccisottiL. BussuF. MiccichèF. RufiniV. Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma.Acta Otorhinolaryngol. Ital.20133311823620633
    [Google Scholar]
  8. XuH. ZhangM. ZhaiG. LiB. The clinical significance of 18F-FDG-PET/CT in early detection of second primary malignancy in cancer patients.J. Cancer Res. Clin. Oncol.201013681125113410.1007/s00432‑010‑0759‑120091320
    [Google Scholar]
  9. IlchevaM. NikolovaP. HadzhiyskaV. MladenovK. Impact of FDG PET/CT on detection of synchronous and metachronous malignancies and clinical management in patients with multiple primary cancers.Neoplasma202269494895610.4149/neo_2022_220203N13535471980
    [Google Scholar]
  10. LiuY. The place of FDG PET/CT in renal cell carcinoma: Value and limitations.Front. Oncol.2016620110.3389/fonc.2016.0020127656421
    [Google Scholar]
  11. HoC. ChenS. LeungY.L. ChengK.C. WongY.H. Dual-tracer PET/CT differentiates 2 types of primary cancers and metastases in a patient with crossed fused renal ectopia.Clin. Nucl. Med.201944215715810.1097/RLU.000000000000239030608912
    [Google Scholar]
  12. WangH.Y. DingH.J. ChenJ.H. ChaoC.H. LuY.Y. LinW.Y. KaoC.H. Meta-analysis of the diagnostic performance of [18F]FDG-PET and PET/CT in renal cell carcinoma.Cancer Imaging201212346447410.1102/1470‑7330.2012.004223108238
    [Google Scholar]
  13. ToguchiM. IshigamiK. GoyaM. SaitoS. MurayamaS. NishieA. Efficacy of pre-operative 18f-fdg pet/ct in prognostic prediction in patients with renal cell carcinoma.Cancer Diagnosis Prognosis20222221622210.21873/cdp.1009735399179
    [Google Scholar]
  14. AlBaqmiK.H. AlMudaiheemF.A. BoghdadlyS. AlHussainiK.A. ShokorN. AlOudahN. Multiple primary malignancies of the colon, stomach, and kidney in a patient with bowel obstruction requiring emergency surgery: A case report.Am. J. Case Rep.202021e92647210.12659/AJCR.92647233243966
    [Google Scholar]
  15. PastorekovaS. GilliesR.J. The role of carbonic anhydrase ix in cancer development: Links to hypoxia, acidosis, and beyond.Cancer Metastasis Rev.2019381-2657710.1007/s10555‑019‑09799‑031076951
    [Google Scholar]
  16. BuiM.H. SeligsonD. HanK.R. PantuckA.J. DoreyF.J. HuangY. HorvathS. LeibovichB.C. ChopraS. LiaoS.Y. StanbridgeE. LermanM.I. PalotieA. FiglinR.A. BelldegrunA.S. Carbonic anhydrase ix is an independent predictor of survival in advanced renal clear cell carcinoma: Implications for prognosis and therapy.Clin. Cancer Res.20039280281112576453
    [Google Scholar]
  17. TatariN. ZhangX. ChafeS.C. McKennaD. LawsonK.A. SubapandithaM. ShaikhM.V. SeyfridM. SavageN. VenugopalC. MoffatJ. SinghS.K. Dual antigen t cell engagers targeting ca9 as an effective immunotherapeutic modality for targeting ca9 in solid tumors.Front. Immunol.20221390576810.3389/fimmu.2022.90576835874663
    [Google Scholar]
  18. ZhangL. HouX. LuS. RaoH. HouJ. LuoR. HuangH. ZhaoH. JianH. ChenZ. LiaoM. WangX. Predictive significance of bone sialoprotein and osteopontin for bone metastases in resected chinese non-small-cell lung cancer patients: A large cohort retrospective study.Lung Cancer201067111411910.1016/j.lungcan.2009.03.01719376608
    [Google Scholar]
  19. WangM. LiuB. LiD. WuY. WuX. JiaoS. XuC. YuS. WangS. YangJ. LiY. WangQ. LuoS. TangH. Upregulation of ibsp expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.Front. Oncol.20199111710.3389/fonc.2019.0111731709184
    [Google Scholar]
  20. XuT. QinR. ZhouJ. YanY. LuY. ZhangX. FuD. LvZ. LiW. XiaC. HuG. DingX. ChenJ. High bone sialoprotein (bsp) expression correlates with increased tumor grade and predicts a poorer prognosis of high-grade glioma patients.PLoS One2012710e4841510.1371/journal.pone.004841523119009
    [Google Scholar]
  21. ChenY. QinY. DaiM. LiuL. NiY. SunQ. LiL. ZhouY. QiuC. JiangY. IBSP, a potential recurrence biomarker, promotes the progression of colorectal cancer via Fyn/β‐catenin signaling pathway.Cancer Med.202110124030404510.1002/cam4.395933987980
    [Google Scholar]
  22. WangH. MeyerC.A. FeiT. WangG. ZhangF. LiuX.S. A systematic approach identifies FOXA1 as a key factor in the loss of epithelial traits during the epithelial-to-mesenchymal transition in lung cancer.BMC Genomics201314168010.1186/1471‑2164‑14‑68024093963
    [Google Scholar]
  23. ChenC. CaoF-H. LiZ-G. ZhangL-G. LiuJ. ChenN. YaoA-L. KangS-S. GaoW-X. HanH. ShenH. ZhangL-J. LiY.P. Bioinformatics analysis of differentially expressed proteins in prostate cancer based on proteomics data.OncoTargets Ther.201691545155710.2147/OTT.S9880727051295
    [Google Scholar]
  24. FanB.L. ZhuW.L. ZouG.L. Cloning and identification of fibrinogen gamma polypeptide (FGG) gene differentially expressed in human hepatocellular carcinoma.Chin. J. Cancer2004233249253
    [Google Scholar]
  25. BloomstonM. ZhouJ.X. RosemurgyA.S. FrankelW. Muro-CachoC.A. YeatmanT.J. Fibrinogen gamma overexpression in pancreatic cancer identified by large-scale proteomic analysis of serum samples.Cancer Res.20066652592259910.1158/0008‑5472.CAN‑05‑365916510577
    [Google Scholar]
  26. KimS.H. ParkJ.Y. JohY.G. HoeH.E. Simultaneous laparoscopic radical nephrectomy and laparoscopic sigmoidectomy for synchronous renal cell carcinoma and colonic adenocarcinoma.J. Laparoendosc. Adv. Surg. Tech. A200414317918110.1089/109264204125549615245672
    [Google Scholar]
  27. NapolitanoC. SantoroG.A. ValvanoL. SalvatiV. MartoranoM. Simultaneous totally laparoscopic radical nephrectomy and laparoscopic left hemicolectomy for synchronous renal and sigmoid colon carcinoma: Report of a case.Int. J. Colorectal Dis.2006211929310.1007/s00384‑004‑0689‑y15668786
    [Google Scholar]
  28. VeenstraG.M. FossionL.M.C.L. de LaetK. LuijtenA.A.P.M. Synchronous laparoscopic radical nephrectomy left and contralateral right hemicolectomy during the same endoscopic procedure.ISRN Surg.201120111410.5402/2011/17945622084746
    [Google Scholar]
  29. NgS.S.M. YiuR.Y.C. LiJ.C.M. ChanC.K. NgC.F. LauJ.Y.W. Endolaparoscopic left hemicolectomy and synchronous laparoscopic radical nephrectomy for obstructive carcinoma of the descending colon and renal cell carcinoma.J. Laparoendosc. Adv. Surg. Tech. A200616329730010.1089/lap.2006.16.29716796445
    [Google Scholar]
  30. FazzinM. DellachiesaL. RestaG. BandiM. MarinoS. AnaniaG. One-stage laparoscopic procedure for a patient with bilateral colorectal tumours and renal carcinoma.G. Chir.201334413213423660167
    [Google Scholar]
  31. TakahashiM. IchikawaR. HonjoK. AokiJ. OkazawaY. KojimaY. IchikawaJ. ShimizuF. HorieS. SakamotoK. Simultaneous laparoscopic colectomy and nephrectomy for synchronous ascending colon cancer and right kidney cancer: Report of a case.Juntendo Med. J.201460434534810.14789/jmj.60.345
    [Google Scholar]
  32. O'SullivanM KearneyDE GiriSK Combined laparoscopic-assisted nephrectomy and complete mesocolic excision for synchronous renal and colon cancers.BMJ Case Rep20152015bcr201521168110.1136/bcr‑2015‑211681
    [Google Scholar]
  33. Martin ArnauA.B. Ochoa VargasC. Peña GonzalezJ.A. Targarona SolerE.M. Simultaneous colectomy and nephectomy in synchronic tumours.Cir. Esp.201593426626810.1016/j.ciresp.2014.04.00625022848
    [Google Scholar]
  34. ImagamiT. TakayamaS. HattoriT. MatsuiR. SakamotoM. KaniH. KurokawaS. FujiwaraT. Combined laparoscopic and robotic surgery for synchronous colorectal and genitourinary cancer: A case series.Int. J. Surg. Case Rep.20185132332710.1016/j.ijscr.2018.09.02130245354
    [Google Scholar]
  35. OritaH. MaekawaH. ImaizumiK. FujitaK. SatoK. One-stage laparoscopic surgery for left renal cell carcinoma and cecal cancer.Int. J. Case Rep. Imag.20189110.5348/100908Z01ST2018CR
    [Google Scholar]
/content/journals/cmim/10.2174/0115734056258908230920063040
Loading
/content/journals/cmim/10.2174/0115734056258908230920063040
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test